Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: J Immunol. 2010 Apr 30;184(11):6256–6265. doi: 10.4049/jimmunol.0901463

Table I.

Flow cytometric analysis of splenic cell populations at 6 and 12 months of age.

Cell population FACS staining 6 months 12 months
Sle16
No= 7
Sle16Sle18
No= 8
Sle18
No= 8
B6
No= 7
Sle16
No= 14
Sle16Sle18
No= 12
Sle18
No= 8
B6
No= 11
Cells (106 /ml) 62.18 ± 4.47$ 38.49 ± 5.67 39.99 ± 5.02 43.09 ± 3.13 92.57 ± 6.99***, $$, 52.33 ± 2.77 50 ± 2.93 38.94 ± 4.77
% B cells
(No ×106)
CD19+ 44.97 ± 2.2
(27.34 ± 2.48$)
44.15 ± 1.36
(16.99 ± 2.54)
45.92 ± 2.46
(18.29 ± 2.23)
37.49 ± 1.65
(16.37 ± 1.76)
42.29 ± 1.18*, $$$
(38.8 ± 2.73***, )
54.46 ± 1.18
(28.94 ± 1.95)
46.97 ± 2.01
(23.5 ± 1.75)
50.28 ± 2.01
(19.58 ± 2.56)
% T cells
(No ×106)
CD19, CD5+ 40.09 ± 1.57
(25.49 ± 1.85)
43.87 ± 1.33
(16.96 ± 2.69)
42.16 ± 2.76
(17.14 ± 2.91)
45.72 ± 2
(19.62 ± 1.46)
31.71 ± 1.48
(29.33 ± 2.71**, $$, )
28.94 ± 1.69*
(15.34 ± 1.23)
29.67 ± 1.71
(14.89 ± 1.25)
36.22 ± 1.85
(13.96 ± 1.77)
% Plasma cells
(No ×106)
CD19, CD90,CD138+ 0.69 ± 0.26
(0.42 ± 0.16)
0.56 ± 0.11
(0.23 ± 0.05)
0.56 ± 0.09
(0.2 ± 0.02)
0.55 ± 0.03
(0.23 ± 0.01)
2.05 ± 0.19***, †††
(1.94 ± 0.28***, $, †††)
1.35 ± 0.11*
(0.75 ± 0.09**)
0.72 ± 0.07
(0.36 ± 0.04)
0.62 ± 0.09
(0.21 ± 0.02)
% MZ B cells
(No ×106)
CD19gatedCD21highCD23low 8.9 ± 1.64
(2.61 ± 0.55)
11.02 ± 1.18
(1.99 ± 0.46)
11.99 ± 1.2
(2.12 ± 0.28)
9.2 ± 0.45
(1.51 ± 0.20)
6.25 ± 0.69**, $
(2.4 ± 0.32)
9.11 ± 0.56
(2.66 ± 0.28)
6.87 ± 0.68*
(1.59 ± 0.16)
10.78 ± 0.82
(2.21 ± 0.38)
% FZ B cells
(No ×106)
CD19gatedCD21lowCD23high 63.24 ± 3.73
(17.33 ± 2.68)
63.13 ± 2.42*
(10.45 ± 1.28)
62.5 ± 1.18*
(11.55 ± 1.57)
73.43 ± 0.84
(12.09 ± 1.39)
69.27 ± 1.37*
(26.81 ± 1.86***, ††)
67.13 ± 1.74
(19.13 ± 1.08)
68.09 ± 3.79
(16.13 ± 1.8)
61.4 ± 1.26
(11.95 ± 1.54)
% B1a cells
(No ×106)
CD19gatedCD5+ 3.42 ± 0.25
(0.91 ± 0.06$)
2.78 ± 0.25
(0.55 ± 0.06)
3.76 ± 0.28
(0.65 ± 0.05)
3.67 ± 0.16
(0.59 ± 0.05)
2.89 ± 0.17$$
(1.11± 0.1*)
3.98 ± 0.19
(1.19 ± 0.13*)
3.84 ± 0.3
(0.9 ± 0.08)
3.54 ± 0.29
(0.66 ± 0.08)
% activated B cells
(No ×106)
CD19gatedCD69+ 10.22 ± 0.88
(2.85 ± 0.19$, ††)
7.96 ± 0.41
(1.36 ± 0.21)
6.95 ± 0.99
(1.22 ± 0.23)
9.14 ± 0.74
(1.44 ± 0.10)
16.61 ± 0.93***, †††
(6.42 ± 0.61***, †††)
13.78 ± 0.77*, ‡‡
(4.02 ± 0.35*, )
8.61 ± 0.31
(2 ± 0.12)
9.33 ± 0.52
(1.86 ± 0.27)
% activated T cells
(No ×106)
CD4gatedCD69+ 20.56 ± 2.6**
(5.86 ± 0.68*)
19.29 ± 0.87*
(3.18 ± 0.41)
18.69 ± 0.97
(3.21 ± 0.58)
12.89 ± 0.78
(2.55 ± 0.28)
34.54 ± 1.41**
(10.22 ± 1.11***, $, ††)
35.39 ± 1.8***
(5.5 ± 0.58)
26.34 ± 2.72
(3.79 ± 0.34)
22.65 ± 1.27
(3.14 ± 0.41)
% naïve T cells
(No ×106)
CD4gatedCD62L+ 57.84 ± 3.26
(14.6 ± 0.98)
60.37 ± 1.46
(10.55 ± 2.16)
63.37 ± 1.77
(11.11 ± 2.14)
65.52 ± 1.61
(12.94 ± 1.14)
28.76 ± 2.23**, ††
(8.27 ± 1.17)
41.27 ± 2.43
(6.4 ± 0.65)
47.57 ± 3.6
(7.2 ± 0.96)
50.03 ± 2.03
(7.2 ± 1.08)
% Memory T cells
(No ×106)
CD4gatedCD44highCD25 28.39 ± 2.5
(7.43 ± 1.11)
28.51 ± 1.49
(4.59 ± 0.53)
25.74 ± 1.9
(4.11 ± 0.44)
24.04 ± 1.02
(4.67 ± 0.31)
50.19 ± 1.78***
(14.66 ± 1.4***, $, ††)
48.46 ± 1.86***
(7.33 ± 0.58)
41.64 ± 3.3
(6.01 ± 0.45)
33.4 ± 1.49
(4.46 ± 0.43)
% Regulatory T cells
(No ×106)
CD4gatedCD25+FoxP3+ 20.47 ± 1.95**
(5.24 ± 0.7**)
17.61 ± 0.97**
(2.98 ± 0.4)
16.88 ± 0.81*
(2.8 ± 0.37)
10.17 ± 0.3
(2.01 ± 0.2)
27.83 ± 1.51*
(8.18 ± 0.92***, $)
27.62 ± 1.11*
(4.29 ± 0.43)
Not available 22.59 ± 1.23
(3.03 ± 0.32)

Results are shown as mean ± SEM. P values considered significant when <0.05 according to the Kruskal-Wallis test with Dunn’s multiple comparison test. Statistical analysis as follow:

*

any congenic vs B6,

$

Sle16 vs Sle16Sle18,

Sle16 vs Sle18;

Sle16Sle18 vs Sle18.

One symbol: <0.05, two symbols: <0.01, three symbols: <0.001.

CD62L staining was available only for 6 mice. When gated cells are indicated, the percentage refers to the percentage of the gated population. No = number; MZ= marginal zone; FZ: follicular zone.